Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population-Reference-Cited by-同舟云学术

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population

Published:2019-08-15 Issue:5 Volume:33 Page:547-555
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Giorda Carlo Bruno, ,Cioffi Giovanni,Lucci Donata,Nada Elisa,Ognibeni Federica,Mancusi Costantino,Latini Roberto,Maggioni Aldo P.

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-019-06898-6.pdf

Reference31 articles.

1. Swoboda PP, Plein S. Heart failure in diabetic patients. Eur Heart J. 2018;39:1755–7.

2. De Simone G, Devereux RB, Chinali M, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the strong heart study. J Hypertens. 2010;28:353–60.

3. Cioffi G, Giorda CB, Chinali M, di Lenarda A, Faggiano P, Lucci D, et al. DYDA investigators. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. Eur J Prev Cardiol. 2012;19:935–43.

4. Giorda CB, Cioffi G, de Simone G, di Lenarda A, Faggiano P, Latini R, et al. DYDA investigators. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. Eur J Cardiovasc Prev Rehabil. 2011;18:415–23.

5. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function. The Strong Heart Study Circulation. 2000;101:2271–6.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Linagliptin and Empagliflozin Preserves Cardiac Systolic Function in an Ischemia-Reperfusion Injury Mice With Diabetes Mellitus;Cardiology Research;2021

2. Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial;European Journal of Preventive Cardiology;2020-07-28

3. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy;Cardiovascular Diabetology;2020-06-13